News on Humira

Humira

2010-11-30T13:10:48Z

...

Finding pain relief for arthritis

2010-11-29T15:20:55Z

...

Humira Psoriasis

2010-11-02T21:40:32Z

...

Psoriasis

2010-09-11T13:02:47Z

...

Abbott Laboratories Q2 2010 Earnings Call Transcript

2010-11-02T12:08:53Z

...

UK's NICE backs wider choice of arthritis drugs

2010-09-01T12:15:48Z

LONDON (Reuters) - Britain's health cost watchdog has changed tack and recommended that rheumatoid arthritis patients should have more options if they do not respond adequately to treatment with a so-called TNF inhibitor drug.

The Abbott Labs profit tops forecasts on greater Humira sales, raises 2009 profit view

Abbott Laboratories said Wednesday it beat its own expectations for the third quarter as sales of its drug Humira continued to climb, along with sales of medical products and nutritional formula for children.

The Abbott Laboratories on June 29 earned the dubious honor of being on the losing side of one of the largest patent verdicts in U.S. history. A federal jury ordered the company to pay nearly $1.7 billion to Johnson &amp; Johnson for infringing on a patent related to the manufacture of Reuters) - A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories &lt;ABT.N&gt; in a patent suit brought by Johnson &amp; Johnson &lt;JNJ.N&...

How to Treat Psoriasis

2010-10-21T11:16:03Z

...

Humira Stops Joint Damage For 5 Years in Early RA

2010-10-23T16:02:22Z

...

Safety a problem for new generation drugs, too

2010-09-01T12:15:45Z

New-generation biotech drugs also turn up side effects, safety warnings after hitting market

Nearly a fourth of widely used new-generation biological drugs for several common diseases produce serious side effects that lead to safety warnings soon after they go on the market, the first major study of its kind found.

Included in the report released Tuesday were the arthritis drugs Humira and

ABBOTT LABORATORIES INC QUARTERLY HUMIRA GLOBAL SALES $1,204 MLN

2010-10-21T09:42:45Z

...

ABBOTT LABS NOW EXPECTS FY 2008 GLOBAL HUMIRA SALES OF MORE THAN $4.4 BILLION

2010-10-21T09:42:46Z

...

Continuous Treatment With Abbott's Humira Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

2010-10-23T16:00:41Z

...

UK health watchdog recommends Abbott's Humira for psoriasis if other drugs fail

2010-10-21T09:35:39Z

...

New Long-Term Humira (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis

2010-10-23T15:58:19Z

...

Humira (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity

2010-10-23T09:21:05Z

...

Humira Approved for Children's Arthritis

2010-10-23T09:55:42Z

...

Abbott Laboratories Q4 2007 Earnings Call Transcript

2010-10-18T14:37:12Z

...

Abbott Laboratories Q3 2007 Earnings Call Transcript

2010-10-15T20:29:11Z

...

Earns Abbott Laboratories

2010-09-01T12:14:19Z

FILE - In this July 13, 2005 file photo provided by Abbott Laboratories, the North Chicago-based company's rheumatoid arthritis therapy Humira, is shown. Abbott Laboratories said Wednesday, July 15, 2009, second-quarter profit fell 3 percent, but the drug and medical-device company met Abbott Laboratories shows the North Chicago-based company's rheumatoid arthritis therapy Humira. Drugmaker Abbott Laboratories said Wednesday, Jan. 21, 2009, its profit grew 28 percent in the fourth quarter as sales of its arthritis drug Humira climbed and the company gained on the sale of...